Chemistry Wealth Management’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
Other funds holding XLV
WA
GG
CCA
FFA
GC
WFA
AIC
BWM
KL
FAC
Chemistry Wealth Management's XLV Position: Q2 2026 in Review
Chemistry Wealth Management reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 0.45% in Q2 2026, selling an estimated $9.82K and leaving 14,490 shares worth $2.3M. The position accounts for 0.37% of the portfolio, ranked #46.
Chemistry Wealth Management first reported a position in XLV in Q1 2022 and has held it in 18 quarters since. 603 funds tracked by Wall St. Rank hold XLV as of Q2 2026.
- Chemistry Wealth Management held 14,490 shares of State Street Health Care Select Sector SPDR ETF worth $2.3M as of Q2 2026.
- Chemistry Wealth Management sold 66 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $9.82K.
- State Street Health Care Select Sector SPDR ETF made up 0.37% of Chemistry Wealth Management's portfolio in Q2 2026, its #46 holding.
- Chemistry Wealth Management first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2022 and has held it in 18 quarters since.
- 603 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.
Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.